An Off-The-Grid Nobel Win, And Antibiotics In Ancient Microbes

Nobel Prize in Physiology or Medicine

• 🏆 Dr. Fred Ramsdell, along with Dr. Shimon Sakaguchi and Dr. Mary E. Bruna, won the Nobel Prize in Physiology or Medicine for their discoveries outlining the role of the peripheral immune system.
• 💡 Ramsdell learned of his win while off-the-grid on a camping trip, receiving the news from his wife after returning to cell service.
• 🔬 Their work identified a key mechanism where regulatory T-cells keep immune cells in check, preventing them from attacking the body's own tissues.

Understanding Autoimmune Diseases

• 🧬 The research stemmed from studying mice with a massive autoimmune disease, leading to the identification and cloning of the FOX P3 gene.
• 🎯 The FOX P3 gene is expressed in a small subset of T-lymphocytes, which are crucial for maintaining peripheral tolerance and preventing the immune system from attacking itself.
• 🧪 This understanding is now being applied in early clinical trials by companies like Sonoma Biotherapeutics to treat various autoimmune diseases, including rheumatoid arthritis, type 1 diabetes, and transplant rejection.

Tackling Antibiotic Resistance

• ⚠️ Dr. César de la Fuente is addressing the antibiotic resistance crisis by exploring unexpected sources for new antibiotics.
• 🦠 His research focuses on archaea, ancient organisms that represent a distinct branch of the tree of life and can survive extreme conditions.
• 💡 Archaea were hypothesized to produce antimicrobial compounds as a defense mechanism against competitors like bacteria, or as part of their host defense.

AI-Powered Antibiotic Discovery

• 🤖 De la Fuente's lab used an AI system called Apex to digitally mine over 200 archaeal proteomes, identifying more than 12,000 potential antimicrobial molecules.
• 🧪 From these, 80 molecules, termed archaosines, were synthesized and experimentally validated.
• ✅ An impressive 93% of these archaosines were effective against clinically relevant pathogens like E. coli and Staphylococcus aureus, demonstrating a high hit rate.

Future of Archaosine Development

• 🔬 Archaosines work by forming polypeptide chains that target and compromise the bacterial membrane, effectively killing bacteria.
• 📈 The research has shown preclinical efficacy in mouse models of infection, a crucial step towards human application.
• ⏳ Significant hurdles remain, including IND enabling studies and extensive clinical trials, as well as ongoing discussions regarding the patentability of these naturally derived but AI-discovered molecules.